Damora Therapeutics Inc (DMRA)

Jun 13, 2026

Damora Therapeutics, Inc. Common Stock (DMRA) Stock Trends and Sentiment 2026 - MarketBeat

Jun 13, 2026

Jun 13, 2026

DMRA Q1 2026 Earnings: EPS Misses Estimates as Clinical Costs WeighEPS Guidance Update - newsline.com

Jun 13, 2026

Jun 13, 2026

Damora Therapeutics, Inc. Common Stock (DMRA) Institutional Ownership 2026 - MarketBeat

Jun 13, 2026

Jun 13, 2026

Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026 - MarketBeat

Jun 13, 2026

Jun 12, 2026

DMRA Reiterates by Wedbush -- Price Target Maintained at $35 - GuruFocus

Jun 12, 2026

Jun 11, 2026

Damora Therapeutics, Inc. Common Stock (DMRA) Stock Chart and Price History 2026 - MarketBeat

Jun 11, 2026

Jun 11, 2026

DMRA Initiated Coverage by HC Wainwright & Co. -- Price Target S - GuruFocus

Jun 11, 2026

Jun 09, 2026

Damora Therapeutics, Inc. Common Stock (DMRA) Earnings Date and Reports 2026 - MarketBeat

Jun 09, 2026

Jun 08, 2026

TD Cowen initiates Damora Therapeutics stock rating at Buy - Investing.com UK

Jun 08, 2026

Jun 08, 2026

TD Cowen initiates Damora Therapeutics stock rating at Buy By Investing.com - Investing.com India

Jun 08, 2026

Jun 08, 2026

Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge - AOL.com

Jun 08, 2026

Jun 01, 2026

Damora Therapeutics Inc (DMRA) SEC filings - GuruFocus

Jun 01, 2026

Jun 01, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jun 01, 2026

Jun 01, 2026

FCPM III Services Buys 2.44 Million Shares of Damora Therapeutics - asatunews.co.id

Jun 01, 2026

May 30, 2026

FCPM III Services Acquires Millions of Damora Therapeutics Shares - HarianBasis.co

May 30, 2026

May 29, 2026

Damora Therapeutics, Inc.Common Stock (Nasdaq:DMRA) Stock Quote - The Chronicle-Journal

May 29, 2026

May 29, 2026

DMRA Q1 2026 Earnings: EPS Misses Estimates by a Wide MarginSubscription Growth Report - newsline.com

May 29, 2026

May 28, 2026

Damora Therapeutics (DMRA) Receives Outperform Rating and $35 Ta - GuruFocus

May 28, 2026

May 28, 2026

DMRA Initiated by Wedbush -- Price Target Announced at $35.00 - GuruFocus

May 28, 2026

May 28, 2026

DMRA Q1 2026 Earnings: EPS Misses Estimates by Over 50%, Stock SlipsOne-Time Gain Impact - newsline.com

May 28, 2026

May 28, 2026

DMRA Technical Analysis & Stock Price Forecast - Intellectia AI

May 28, 2026

May 28, 2026

DMRA Q1 2026 Earnings: Wider-Than-Expected Loss Sends Shares LowerQuarterly Profit Report - The Legal Advocate

May 28, 2026

May 27, 2026

Damora Therapeutics: Well-Funded Moonshot For CALR Mutations (NASDAQ:DMRA) - Seeking Alpha

May 27, 2026

May 26, 2026

Damora Therapeutics (DMRA) Gains 2.4% as Biotech Sector Finds FootingTriple Bottom - newsline.com

May 26, 2026

May 26, 2026

Damora Therapeutics (DMRA) Holds Steady Near Support: Technical Analysis of Key LevelsAnalyst Downgrade Signals - The Legal Advocate

May 26, 2026

May 26, 2026

Damora Therapeutics Holds Steady Near Key Support Amid Quiet TradingAdaptive Moving Average - The Legal Advocate

May 26, 2026

May 26, 2026

Damora Therapeutics’ Deepening Losses Raise a Quiet Question About Its Cost Strategy and Runway (DMRA) - simplywall.st

May 26, 2026